Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$3.27 - $8.76 $4,561 - $12,220
-1,395 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$16.69 - $26.05 $13,101 - $20,449
785 Added 128.69%
1,395 $27,000
Q1 2021

May 14, 2021

SELL
$20.71 - $51.02 $5,985 - $14,744
-289 Reduced 32.15%
610 $15,000
Q4 2020

Feb 16, 2021

BUY
$21.84 - $44.0 $19,634 - $39,556
899 New
899 $33,000

Others Institutions Holding PSNL

About Personalis, Inc.


  • Ticker PSNL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 45,918,400
  • Market Cap $180M
  • Description
  • Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...
More about PSNL
Track This Portfolio

Track Macquarie Group LTD Portfolio

Follow Macquarie Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.